Prenetics Global Limited (NASDAQ:PRENW – Get Free Report) was the recipient of a large decrease in short interest in the month of July. As of July 31st, there was short interest totaling 27,675 shares, a decrease of 96.5% from the July 15th total of 787,526 shares. Based on an average daily volume of 29,679 shares, the days-to-cover ratio is presently 0.9 days.
Prenetics Global Stock Performance
NASDAQ PRENW traded up $0.00 during trading on Wednesday, hitting $0.01. The company’s stock had a trading volume of 6,523 shares, compared to its average volume of 38,810. The firm has a 50 day moving average price of $0.01 and a 200 day moving average price of $0.02. Prenetics Global has a 52 week low of $0.01 and a 52 week high of $0.04.
Prenetics Global Company Profile
Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.
Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.
See Also
- Five stocks we like better than Prenetics Global
- Intel’s Rally Gave It a $20 Billion Opportunity and Now Comes the Hard Part
- Visa’s AI Opportunity Is Hiding in Every Transaction
- On Holding’s Price Stumble May Be an Opening for a Company Built to Run
- TSMC’s 44.7% Sales Surge Signals the AI Boom Is Still Alive
Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.
